About Minster Pharmaceuticals
Minster Pharmaceuticals is a company based in London (United Kingdom) founded in 2001 was acquired by Proximagen in January 2010. Minster Pharmaceuticals operates in a competitive market with competitors including Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and PainReform, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Proximagen
(Jan 04, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Minster Pharmaceuticals
Detailed funding history for Minster Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Minster Pharmaceuticals
Minster Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Proximagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Small molecules for neurodegenerative disorders, including Parkinson’s and Alzheimers.
|
Locked | Locked | Locked |
Investor details for Minster Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Minster Pharmaceuticals
Investment portfolio details for Minster Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Minster Pharmaceuticals
Detailed financials for Minster Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Minster Pharmaceuticals Comparisons
Peer comparison for Minster Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Minster Pharmaceuticals
Minster Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Eliem Therapeutics, Zogenix, Heron Therapeutics and PainReform, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| Locked | Locked | Locked |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| Locked | Locked | Locked |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| Locked | Locked | Locked |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| Locked | Locked | Locked |
Pain treatment products are developed through reformulation technologies.
|
|
| Locked | Locked | Locked |
Therapeutics for pain management are developed with abuse-deterrent designs.
|
Detailed competitors of Minster Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Minster Pharmaceuticals
Complete news archive for Minster Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Minster Pharmaceuticals
Minster Pharmaceuticals was founded in 2001.
Minster Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Minster Pharmaceuticals was established in 2001 in London, United Kingdom, within the pharmaceutical sector. Focus was placed on developing treatments for central nervous system conditions, particularly migraine. Operations centered on advancing drug candidates through clinical trials. The lead product, tonabersat, underwent Phase 3 evaluation but did not succeed in February 2009. Acquisition by Proximagen occurred in January 2010, concluding independent activities.
Minster Pharmaceuticals's top competitors include Flexion Therapeutics, Cara Therapeutics and Satsuma Pharmaceuticals.
Minster Pharmaceuticals has 1 investor. Key investors include Proximagen.